EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Applicability of colon capsule endoscopy in FIT-positive individuals unable or unwilling to undergo colonoscopy within a colorectal cancer screening programme: a prospective multicentre study

Fleur E Marijnissen iD, Sarah Moen, Conny C G van Enckevort, Ivonne Leeuwenburgh, Ruud W M Schrauwen, Leonieke Wolters, Manon C W Spaander

Therapeutic Advances in Gastrointestinal Endoscopy · 2026-01 · 19

DOI: 10.1177/26317745251415118 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Therapeutic Advances in Gastrointestinal Endoscopy, online erschienen am 26.01.2026. Verfasst von Fleur E Marijnissen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: MDL fonds.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Colorectal cancer (CRC) screening programmes commonly use the Faecal immunochemical test (FIT) followed by colonoscopy. When colonoscopy is not feasible, computed tomography colonography (CTC) serves as an alternative. However, CTC has limitations, such as lower sensitivity for smaller polyps and radiation exposure. Colon capsule endoscopy (CCE) is a non-invasive alternative that may improve polyp detection in FIT-positive individuals.

Objectives

To evaluate the feasibility of CCE in FIT-positive participants from the Dutch CRC screening programme who are unable or unwilling to undergo colonoscopy.

Design

Prospective multicentre, interventional study.

Methods

FIT-positive participants ingested the PillCam ® Colon 2 capsule. Colonoscopy was recommended if polyp(s) ⩾6 or suspected malignancy were detected. The primary outcome was the per-patient polyp detection rate (PDR) for polyps ⩾6 mm.

Results

Of 169 FIT-positive participants unable to undergo colonoscopy, 54.4% were ineligible for CCE due to contraindications. CCE was performed in 13 participants, with a completion rate of 69.2% and adequate bowel preparation in 38.5. A total of 54 polyps were detected, 46.3% of which were ⩾6 mm. The per-patient detection rate for polyps ⩾6 mm was 76.9%. In 84.6% of cases, follow-up colonoscopy was advised. CCE findings matched colonoscopy in 66.7% of cases; in the remaining 33.3%, polyps were found to be < 6 mm during colonoscopy. One participant was diagnosed with a pT4bN0M0 adenocarcinoma after CCE revealed a tumorous obstruction.

Conclusion

Despite a high per-patient PDR, this study indicates that CCE is less suitable for FIT-positive individuals unable or unwilling to undergo colonoscopy due to high comorbidity and frequent contraindications. Inadequate bowel preparation, likely due to reduced gastrointestinal motility, further limited feasibility. Given the elevated risk of advanced neoplasia in this population, many still required follow-up colonoscopy. Therefore, CCE may be better suited for lower-risk populations with fewer procedural limitations.

Trial registration

Overview of Medical Research in the Netherlands, NL-OMON55511.

Schlagwörter

Stichwörter der Autor:innen

CT-colonographycolon capsule endoscopycolonic polypscolorectal cancer screening

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Department of Gastroenterology and Hepatology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands.
  • Department of Gastroenterology and Hepatology, Franciscus Gasthuis en Vlietland, Rotterdam, The Netherlands.
  • Department of Gastroenterology and Hepatology, Bernhoven Hospital, Uden, The Netherlands.
  • Department of Gastroenterology and Hepatology, Albert Schweitzer Hospital, Dordrecht, The Netherlands.
  • Department of Gastroenterology and Hepatology, Erasmus University Medical Center Rotterdam, Room Na-612, P.O. Box 2040, Rotterdam 3000 CA, The Netherlands.

ORCID-Profile: Fleur E Marijnissen

Förderung

  • MDL fonds

Zitieren

APA

Marijnissen, F. E., Moen, S., van Enckevort, C. C. G., Leeuwenburgh, I., Schrauwen, R. W. M., Wolters, L., & Spaander, M. C. W. (2026). Applicability of colon capsule endoscopy in FIT-positive individuals unable or unwilling to undergo colonoscopy within a colorectal cancer screening programme: a prospective multicentre study. Therapeutic Advances in Gastrointestinal Endoscopy, 19. https://doi.org/10.1177/26317745251415118

Vancouver

Marijnissen FE, Moen S, van Enckevort CCG, Leeuwenburgh I, Schrauwen RWM, Wolters L, et al. Applicability of colon capsule endoscopy in FIT-positive individuals unable or unwilling to undergo colonoscopy within a colorectal cancer screening programme: a prospective multicentre study. Therapeutic Advances in Gastrointestinal Endoscopy. 2026;19. doi:10.1177/26317745251415118

BibTeX
@article{Marijnissen2026,
  author = {Marijnissen, Fleur E and Moen, Sarah and van Enckevort, Conny C G and Leeuwenburgh, Ivonne and Schrauwen, Ruud W M and Wolters, Leonieke and Spaander, Manon C W},
  title = {Applicability of colon capsule endoscopy in FIT-positive individuals unable or unwilling to undergo colonoscopy within a colorectal cancer screening programme: a prospective multicentre study},
  journal = {Therapeutic Advances in Gastrointestinal Endoscopy},
  year = {2026},
  volume = {19},
  doi = {10.1177/26317745251415118}
}
Kostenlos starten →